Blood Cancer J

PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia.

Shah K, Nasimian A, Ahmed M, ..., Lock RB, Kazi JU

Blood Cancer J 13 (1) 139 [2023-09-07; online 2023-09-07]

Bioinformatics (NBIS) [Collaborative] Bioinformatics Support and Infrastructure [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative]

Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia.

Österroos A, Björklund M, Eriksson A, ..., Grönberg H, Lehmann S

Blood Cancer J 10 (6) 67 [2020-06-11; online 2020-06-11]

Bioinformatics Support for Computational Resources [Service]

DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma.

Haider Z, Landfors M, Golovleva I, ..., Hultdin M, Degerman S

Blood Cancer J 10 (4) 45 [2020-04-28; online 2020-04-28]

Clinical Genomics [Service] Clinical Genomics Umeå [Service]

Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.

Barreca A, Martinengo C, Annaratone L, ..., van Oudenaarden A, Chiarle R

Blood Cancer J 4 (-) e249 [2014-10-10; online 2014-10-10]

Advanced FISH Technologies [Collaborative]

The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Eriksson A, Hermanson M, Wickström M, ..., Parrow V, Höglund M

Blood Cancer J 2 (8) e81 [2012-08-00; online 2012-08-00]

Chemical Biology Consortium Sweden (CBCS) [Collaborative]